Comparison of botulinum toxin injection and neurotomy in patients with distal lower limb spasticity

European Journal of Neurology

Volumn 15, Issue 5, 2008, Pages 506-511

  Rousseaux, M ^a   Buisset, N ^a   Daveluy, W ^a   Kozlowski, O ^a   Blond, S ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Botulinum toxin; Neurotomy; Spasticity; Stroke

Indexed keywords

BACLOFEN; BOTULINUM TOXIN A; DANTROLENE;

ACHILLES REFLEX; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DYSESTHESIA; FATIGUE; FEMALE; GAIT; HUMAN; HYPESTHESIA; LEG CRAMP; LEG MOVEMENT; MALE; MOTOR CONTROL; MUSCLE WEAKNESS; NERVE SURGERY; PAIN; PHYSIOTHERAPY; POSTOPERATIVE PAIN; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SPASTICITY; SURGICAL TECHNIQUE; TIBIAL NERVE; WALKING AID;

EID: 41849126365     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02112.x     Document Type: Article

References (26)

1. Kirazli Y, On AY, Kismali B, Aksit R. Comparison of phenol block and botulinus toxin type A in the treatment of spastic foot after stroke: a randomized, double-blind trial. American Journal of Physical Medicine and Rehabilitation 1998 77 : 510 515.
2. Burbaud P, Wiart L, Dubos JL, et al. A randomised, double blind, placebo controlled trial of botulinum toxin in the treatment of spastic foot in hemiparetic patients. Journal of Neurology, Neurosurgery and Psychiatry 1996 61 : 265 269.
3. Hesse S, Lucke D, Malezic M, et al. Botulinum toxin treatment for lower limb extensor spasticity in chronic hemiparetic patients. Journal of Neurology, Neurosurgery and Psychiatry 1994 57 : 1321 1324.
4. Rousseaux M, Compère S, Launay MJ, Kozlowski O. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles. Journal of the Neurological Sciences 2005 232 : 51 57.
5. Mancini F, Sandrini G, Moglia A, Nappi G, Pacchetti C. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot. Neurological Sciences 2005 26 : 26 31.
6. ®) in the treatment of spastic equinovarus deformity after stroke. Cerebrovascular Disorders 2003 15 : 289 300.
7. Richardson D, Sheean G, Werring D, et al. Evaluating the role of botulinum toxin in the management of focal hypertonia in adults. Journal of Neurology, Neurosurgery and Psychiatry 2000 69 : 499 506.
8. Cioni M, Esquenazi A, Hirai B. Effects of botulinum toxin-A on gait velocity, step length, and base of support of patients with dynamic equinovarus foot. American Journal of Physical Medicine and Rehabilitation 2006 85 : 600 606.
9. Yelnik A, Colle F, Bonan I, Bradai N. Efficacitéà six mois de la toxine botulique A dans le traitement de l'hyperactivité musculaire du membre inférieur après accident vasculaire cérébral. Annales de Réadaptation et de Médecine Physique 2002 45 : 159 165.
10. Decq P, Filipetti P, Cubillos A, Slavov V, Lefaucheur JP, Nguyen JP. Soleus neurotomy for treatment of the spastic equinus foot. Groupe d'Evaluation et de Traitement de la Spasticité et de la Dystonie. Neurosurgery 2000 47 : 1154 1160.
11. Sindou M, Mertens P. Selective neurotomy of the tibial nerve for the treatment of the spastic foot. Neurosurgery 1988 23 : 738 744.
12. Caillet F, Mertens P, Rabaseda S, Boisson D. Intérêt de l'analyse tridimentionnelle de la marche, dans la prise en charge du pied spastique. Annales de Réadaptation et de Médecine Physique 2003 46 : 119 131.
13. Deltombe T, Detrembleur C, Hanson P, Gustin T. Selective tibial neurotomy in the treatment of spastic equinovarus foot: a 2-year follow-up of three cases. American Journal of Physical Medicine and Rehabilitation 2006 85 : 82 88.
14. Buffenoir K, Roujeau T, Lapierre F, et al. Spastic equinus foot: multicenter study of the long-term results of tibial neurotomy. Neurosurgery 2004 55 : 1130 1137.
15. Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth Scale of muscle spasticity. Physical Therapy 1987 67 : 206 207.
16. Demeurisse G, Demol O, Robaye E. Motor evaluation in vascular hemiplegia. European Neurology 1980 19 : 382 389.
17. Brun V, Dhoms G, Henrion G, Codine P, Founeau H, Terraza M. L'équilibre postural de l'hémiplégique par accident vasculaire cérébral: méthodologie d'évaluation et étude corrélative. Annales de Réadaptation et de Médecine Physique 1993 36 : 169 177.
18. Holden MK, Gill KM, Magliozzi MR, Nathan J, Piehl-Baker L. Clinical gait assessment in the neurologically impaired: reliability and meaningfulness. Physical Therapy 1984 64 : 35 40.
19. Lincoln N, Leadbitter D. Assessment of motor function in stroke patients. Physiotherapy 1979 65 : 48 51.
20. Simpson DM, Alexander DN, O'Brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology 1996 46 : 1306 1310.
21. Filipetti P, Decq P, Fontaine D, et al. La spasticité des membres inférieurs chez l'adulte. Evaluation clinique et blocs moteurs. Neuro-Chirurgie 1998 44 : 167 174.
22. Collado H, Bensoussan L, Viton JM, Milhe De Bovis V, Delarque A. Does fascicular neurotomy have long-lasting effects? Journal of Rehabilitation Medicine 2006 38 : 212 217.
23. Tabary JC, Tabary C, Tardieu C, Tardieu G, Goldspink G. Physiological and structural changes in the cat's soleus muscle due to immobilization at different lengths by plaster casts. Journal of Physiology (London) 1972 224 : 231 244.
24. Dietz V, Quintern J, Berger W. Electrophysiological studies of gait in spasticity and rigidity. Evidence that altered mechanical properties of muscle contribute to hypertonia. Brain 1981 104 : 431 449.
25. O'Dwyer NJ, Ada L, Neilson PD. Spasticity and muscle contracture following stroke. Brain 1996 119 : 1737 1749.
26. Trappier T, Bensoussan L, Milhe V, Viton JM, Delarque A. Influence sur le contrôle postural du traitement par toxine botulique chez les sujets cérébrolésés. Annales de Réadaptation et de Médecine Physique 2006 49 : 155 165.